Literature DB >> 23165068

Biomarkers. Screening for C-reactive protein in CVD prediction.

Sanne A E Peters1, Frank L J Visseren, Diederick E Grobbee.   

Abstract

Adding C-reactive protein (CRP) level to conventional cardiovascular risk models has been suggested to improve risk prediction for cardiovascular events. However, evaluation of the potential impact of CRP measurement in cardiovascular risk management will require studies designed to quantify the effect of additional CRP assessment on medical decision-making, patient outcomes, and cost-effectiveness.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23165068     DOI： 10.1038/nrcardio.2012.164

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


  10 in total

1.  2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Philip Greenland; Joseph S Alpert; George A Beller; Emelia J Benjamin; Matthew J Budoff; Zahi A Fayad; Elyse Foster; Mark A Hlatky; John McB Hodgson; Frederick G Kushner; Michael S Lauer; Leslee J Shaw; Sidney C Smith; Allen J Taylor; William S Weintraub; Nanette K Wenger; Alice K Jacobs; Sidney C Smith; Jeffrey L Anderson; Nancy Albert; Christopher E Buller; Mark A Creager; Steven M Ettinger; Robert A Guyton; Jonathan L Halperin; Judith S Hochman; Frederick G Kushner; Rick Nishimura; E Magnus Ohman; Richard L Page; William G Stevenson; Lynn G Tarkington; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2010-12-14       Impact factor: 24.094

2.  Prognosis and prognostic research: application and impact of prognostic models in clinical practice.

Authors:  Karel G M Moons; Douglas G Altman; Yvonne Vergouwe; Patrick Royston
Journal:  BMJ       Date:  2009-06-04

Review 3.  2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations.

Authors:  Jacques Genest; Ruth McPherson; Jiri Frohlich; Todd Anderson; Norm Campbell; André Carpentier; Patrick Couture; Robert Dufour; George Fodor; Gordon A Francis; Steven Grover; Milan Gupta; Robert A Hegele; David C Lau; Lawrence Leiter; Gary F Lewis; Eva Lonn; G B John Mancini; Dominic Ng; Glen J Pearson; Allan Sniderman; James A Stone; Ehud Ur
Journal:  Can J Cardiol       Date:  2009-10       Impact factor: 5.223

4.  Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study.

Authors:  Maryam Kavousi; Suzette Elias-Smale; Joost H W Rutten; Maarten J G Leening; Rozemarijn Vliegenthart; Germaine C Verwoert; Gabriel P Krestin; Matthijs Oudkerk; Moniek P M de Maat; Frank W G Leebeek; Francesco U S Mattace-Raso; Jan Lindemans; Albert Hofman; Ewout W Steyerberg; Aad van der Lugt; Anton H van den Meiracker; Jacqueline C M Witteman
Journal:  Ann Intern Med       Date:  2012-03-20       Impact factor: 25.391

5.  Coronary artery calcium score and risk classification for coronary heart disease prediction.

Authors:  Tamar S Polonsky; Robyn L McClelland; Neal W Jorgensen; Diane E Bild; Gregory L Burke; Alan D Guerci; Philip Greenland
Journal:  JAMA       Date:  2010-04-28       Impact factor: 56.272

6.  Decision curve analysis: a novel method for evaluating prediction models.

Authors:  Andrew J Vickers; Elena B Elkin
Journal:  Med Decis Making       Date:  2006 Nov-Dec       Impact factor: 2.583

7.  Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis.

Authors:  Hester M Den Ruijter; Sanne A E Peters; Todd J Anderson; Annie R Britton; Jacqueline M Dekker; Marinus J Eijkemans; Gunnar Engström; Gregory W Evans; Jacqueline de Graaf; Diederick E Grobbee; Bo Hedblad; Albert Hofman; Suzanne Holewijn; Ai Ikeda; Maryam Kavousi; Kazuo Kitagawa; Akihiko Kitamura; Hendrik Koffijberg; Eva M Lonn; Matthias W Lorenz; Ellisiv B Mathiesen; Giel Nijpels; Shuhei Okazaki; Daniel H O'Leary; Joseph F Polak; Jackie F Price; Christine Robertson; Christopher M Rembold; Maria Rosvall; Tatjana Rundek; Jukka T Salonen; Matthias Sitzer; Coen D A Stehouwer; Jacqueline C Witteman; Karel G Moons; Michiel L Bots
Journal:  JAMA       Date:  2012-08-22       Impact factor: 56.272

8.  General cardiovascular risk profile for use in primary care: the Framingham Heart Study.

Authors:  Ralph B D'Agostino; Ramachandran S Vasan; Michael J Pencina; Philip A Wolf; Mark Cobain; Joseph M Massaro; William B Kannel
Journal:  Circulation       Date:  2008-01-22       Impact factor: 29.690

9.  Impact of adding a single allele in the 9p21 locus to traditional risk factors on reclassification of coronary heart disease risk and implications for lipid-modifying therapy in the Atherosclerosis Risk in Communities study.

Authors:  Ariel Brautbar; Christie M Ballantyne; Kim Lawson; Vijay Nambi; Lloyd Chambless; Aaron R Folsom; James T Willerson; Eric Boerwinkle
Journal:  Circ Cardiovasc Genet       Date:  2009-04-21

10.  C-reactive protein, fibrinogen, and cardiovascular disease prediction.

Authors:  Stephen Kaptoge; Emanuele Di Angelantonio; Lisa Pennells; Angela M Wood; Ian R White; Pei Gao; Matthew Walker; Alexander Thompson; Nadeem Sarwar; Muriel Caslake; Adam S Butterworth; Philippe Amouyel; Gerd Assmann; Stephan J L Bakker; Elizabeth L M Barr; Elizabeth Barrett-Connor; Emelia J Benjamin; Cecilia Björkelund; Hermann Brenner; Eric Brunner; Robert Clarke; Jackie A Cooper; Peter Cremer; Mary Cushman; Gilles R Dagenais; Ralph B D'Agostino; Rachel Dankner; George Davey-Smith; Dorly Deeg; Jacqueline M Dekker; Gunnar Engström; Aaron R Folsom; F Gerry R Fowkes; John Gallacher; J Michael Gaziano; Simona Giampaoli; Richard F Gillum; Albert Hofman; Barbara V Howard; Erik Ingelsson; Hiroyasu Iso; Torben Jørgensen; Stefan Kiechl; Akihiko Kitamura; Yutaka Kiyohara; Wolfgang Koenig; Daan Kromhout; Lewis H Kuller; Debbie A Lawlor; Tom W Meade; Aulikki Nissinen; Børge G Nordestgaard; Altan Onat; Demosthenes B Panagiotakos; Bruce M Psaty; Beatriz Rodriguez; Annika Rosengren; Veikko Salomaa; Jussi Kauhanen; Jukka T Salonen; Jonathan A Shaffer; Steven Shea; Ian Ford; Coen D A Stehouwer; Timo E Strandberg; Robert W Tipping; Alberto Tosetto; Sylvia Wassertheil-Smoller; Patrik Wennberg; Rudi G Westendorp; Peter H Whincup; Lars Wilhelmsen; Mark Woodward; Gordon D O Lowe; Nicholas J Wareham; Kay-Tee Khaw; Naveed Sattar; Chris J Packard; Vilmundur Gudnason; Paul M Ridker; Mark B Pepys; Simon G Thompson; John Danesh
Journal:  N Engl J Med       Date:  2012-10-04       Impact factor: 91.245
  10 in total
  3 in total

1.  Combined influence of depressive symptoms and systemic inflammation on all-cause and cardiovascular mortality: evidence for differential effects by gender in the English Longitudinal Study of Ageing.

Authors:  Samantha Lawes; Panayotes Demakakos; Andrew Steptoe; Glyn Lewis; Livia A Carvalho
Journal:  Psychol Med       Date:  2018-09-17       Impact factor: 7.723

Review 2.  Selective Apheresis of C-Reactive Protein for Treatment of Indications with Elevated CRP Concentrations.

Authors:  Stefan Kayser; Patrizia Brunner; Katharina Althaus; Johannes Dorst; Ahmed Sheriff
Journal:  J Clin Med       Date:  2020-09-12       Impact factor: 4.241

Review 3.  [CRP apheresis in acute myocardial infarction and COVID-19].

Authors:  Michael Buerke; Ahmed Sheriff; Christoph D Garlichs
Journal:  Med Klin Intensivmed Notfmed       Date:  2022-03-25       Impact factor: 1.552
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.